Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

3.37
Delayed Data
As of Dec 02
 +0.19 / +5.97%
Today’s Change
1.77
Today|||52-Week Range
10.98
-63.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization5.0K10.3K40.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income-5.0K-10.3K-40.0K-41.0K
 
 
 
 
 
General Expenses7.2M8.2M8.0M7.5M
 
 
 
 
 
Research And Development3.5M4.9M4.5M3.9M
 
 
 
 
 
Total Operating Expenses7.2M8.2M8.0M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.2M-8.2M-8.0M-7.5M
 
 
 
 
 
Other Expenses-1.0K0.000.00-3.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-7.6M-7.5M-7.0M
 
 
 
 
 
Net Income-6.7M-7.6M-7.5M-7.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.8M24.8M24.9M24.9M
 
 
 
 
 
Shares To Calculate EPS Diluted24.8M24.8M24.9M24.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.30-$0.30-$0.28
 
 
 
 
 
EPS Diluted-$0.27-$0.31-$0.30-$0.28